Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Intravitreal injections of pegaptanib every 4 weeks will be efficacious in treating Diabetic
Macular Edema (DME), as compared to injections every 6 weeks.